Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer
Publication date
2021-03-10
Authors
Crockett, Cathryn B
Samson, Pamela
Chuter, Robert
Dubec, Michael
Faivre-Finn, Corinne
Green, Olga L
Hackett, Sara L
McDonald, Fiona
Robinson, Clifford
Shiarli, Anna-Maria
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Curative-intent radiotherapy plays an integral role in the treatment of lung cancer and therefore improving its therapeutic index is vital. MR guided radiotherapy (MRgRT) systems are the latest technological advance which may help with achieving this aim. The majority of MRgRT treatments delivered to date have been stereotactic body radiation therapy (SBRT) based and include the treatment of (ultra-) central tumors. However, there is a move to also implement MRgRT as curative-intent treatment for patients with inoperable locally advanced NSCLC. This paper presents the initial clinical experience of using the two commercially available systems to date: the ViewRay MRIdian and Elekta Unity. The challenges and potential solutions associated with MRgRT in lung cancer will also be highlighted.
Keywords
adaptive, external beam radiotherapy, image-guided radiotherapy (IGRT), magnetic resonance imaging (MRI), MR-guided radiotherapy (MRgRT), non-small cell lung cancer (NSCLC), stereotactic body radiation therapy (SBRT), Oncology, Cancer Research, Journal Article
Citation
Crockett, C B, Samson, P, Chuter, R, Dubec, M, Faivre-Finn, C, Green, O L, Hackett, S L, McDonald, F, Robinson, C, Shiarli, A-M, Straza, M W, Verhoeff, J J C, Werner-Wasik, M, Vlacich, G & Cobben, D 2021, 'Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer', Frontiers in oncology, vol. 11, 617681, pp. 617681. https://doi.org/10.3389/fonc.2021.617681